These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26193998)
1. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome? Archer NM; Amorim RP; Naves R; Hettmer S; Diller LR; Ribeiro KB; Rodriguez-Galindo C Pediatr Blood Cancer; 2016 Feb; 63(2):196-201. PubMed ID: 26193998 [TBL] [Abstract][Full Text] [Related]
2. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma. Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228 [TBL] [Abstract][Full Text] [Related]
3. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212 [TBL] [Abstract][Full Text] [Related]
4. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110 [TBL] [Abstract][Full Text] [Related]
5. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study. Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326 [TBL] [Abstract][Full Text] [Related]
6. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor. Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878 [TBL] [Abstract][Full Text] [Related]
8. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study. Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769 [TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working Group Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [TBL] [Abstract][Full Text] [Related]
10. Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries. Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Olsen JH; Tracey E; Pukkala E; Weiderpass E; Brewster DH; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P Int J Cancer; 2011 Oct; 129(8):1940-52. PubMed ID: 21520035 [TBL] [Abstract][Full Text] [Related]
11. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074 [TBL] [Abstract][Full Text] [Related]
12. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362 [TBL] [Abstract][Full Text] [Related]
13. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program. Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745 [TBL] [Abstract][Full Text] [Related]
14. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732 [TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. Applebaum MA; Vaksman Z; Lee SM; Hungate EA; Henderson TO; London WB; Pinto N; Volchenboum SL; Park JR; Naranjo A; Hero B; Pearson AD; Stranger BE; Cohn SL; Diskin SJ Eur J Cancer; 2017 Feb; 72():177-185. PubMed ID: 28033528 [TBL] [Abstract][Full Text] [Related]
16. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. Heyn R; Haeberlen V; Newton WA; Ragab AH; Raney RB; Tefft M; Wharam M; Ensign LG; Maurer HM J Clin Oncol; 1993 Feb; 11(2):262-70. PubMed ID: 8426203 [TBL] [Abstract][Full Text] [Related]
17. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. Hisada M; Chen BE; Jaffe ES; Travis LB J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716 [TBL] [Abstract][Full Text] [Related]
18. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database. Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090 [TBL] [Abstract][Full Text] [Related]
19. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718 [TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma in children: a SEER population based study. Perez EA; Kassira N; Cheung MC; Koniaris LG; Neville HL; Sola JE J Surg Res; 2011 Oct; 170(2):e243-51. PubMed ID: 21529833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]